ID   FAT4_MOUSE              Reviewed;        4981 AA.
AC   Q2PZL6; E9QMR9; Q68FE0; Q8BM82; Q8CD68;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   07-APR-2021, entry version 132.
DE   RecName: Full=Protocadherin Fat 4;
DE   AltName: Full=FAT tumor suppressor homolog 4;
DE   AltName: Full=Fat-like cadherin protein FAT-J;
DE   Flags: Precursor;
GN   Name=Fat4; Synonyms=Fatj;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Qi C., Zhu Y.T., Hu L., Zhang Z., Rao S.M., Zhu Y.-J.;
RT   "Identification of Fat4 as the candidate tumor suppressor gene in breast
RT   cancers through random chromosome deletion.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1329-4981 (ISOFORM 2), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4473-4981 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Embryo, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2963-4981 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4878, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic brain;
RX   PubMed=15345747; DOI=10.1074/mcp.m400085-mcp200;
RA   Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.;
RT   "Phosphoproteomic analysis of the developing mouse brain.";
RL   Mol. Cell. Proteomics 3:1093-1101(2004).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=16059920; DOI=10.1002/dvdy.20515;
RA   Rock R., Schrauth S., Gessler M.;
RT   "Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the
RT   planar cell polarity pathway identified in Drosophila.";
RL   Dev. Dyn. 234:747-755(2005).
RN   [7]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=18604206; DOI=10.1038/ng.179;
RA   Saburi S., Hester I., Fischer E., Pontoglio M., Eremina V., Gessler M.,
RA   Quaggin S.E., Harrison R., Mount R., McNeill H.;
RT   "Loss of Fat4 disrupts PCP signaling and oriented cell division and leads
RT   to cystic kidney disease.";
RL   Nat. Genet. 40:1010-1015(2008).
RN   [8]
RP   HETEROPHILIC INTERACTION WITH DCHS1, AND INTERACTION WITH MPDZ.
RX   PubMed=19506035; DOI=10.1083/jcb.200811030;
RA   Ishiuchi T., Misaki K., Yonemura S., Takeichi M., Tanoue T.;
RT   "Mammalian Fat and Dachsous cadherins regulate apical membrane organization
RT   in the embryonic cerebral cortex.";
RL   J. Cell Biol. 185:959-967(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=21303848; DOI=10.1242/dev.057166;
RA   Mao Y., Mulvaney J., Zakaria S., Yu T., Morgan K.M., Allen S., Basson M.A.,
RA   Francis-West P., Irvine K.D.;
RT   "Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-
RT   Fat4 signaling during mammalian development.";
RL   Development 138:947-957(2011).
RN   [11]
RP   DISRUPTION PHENOTYPE, DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=24056717; DOI=10.1038/ng.2765;
RA   Cappello S., Gray M.J., Badouel C., Lange S., Einsiedler M., Srour M.,
RA   Chitayat D., Hamdan F.F., Jenkins Z.A., Morgan T., Preitner N., Uster T.,
RA   Thomas J., Shannon P., Morrison V., Di Donato N., Van Maldergem L.,
RA   Neuhann T., Newbury-Ecob R., Swinkells M., Terhal P., Wilson L.C.,
RA   Zwijnenburg P.J., Sutherland-Smith A.J., Black M.A., Markie D.,
RA   Michaud J.L., Simpson M.A., Mansour S., McNeill H., Goetz M.,
RA   Robertson S.P.;
RT   "Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and
RT   FAT4 disrupt cerebral cortical development.";
RL   Nat. Genet. 45:1300-1308(2013).
CC   -!- FUNCTION: Cadherins are cell-cell interaction molecules. FAT4 plays a
CC       role in the maintenance of planar cell polarity as well as in
CC       inhibition of YAP1-mediated neuroprogenitor cell proliferation and
CC       differentiation. {ECO:0000269|PubMed:18604206,
CC       ECO:0000269|PubMed:24056717}.
CC   -!- SUBUNIT: Heterophilic interaction with DCHS1; this interaction affects
CC       their respective protein levels. Interacts (via cytoplasmic domain)
CC       with MPDZ. Forms a complex with MPP5 and MPDZ.
CC       {ECO:0000269|PubMed:19506035}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}. Note=In the kidney, localizes to
CC       primary cilia. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q2PZL6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2PZL6-2; Sequence=VSP_032339, VSP_032340;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:16059920}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in all layers of the developing brain,
CC       with expression being most prominent at the ventricular margin.
CC       {ECO:0000269|PubMed:24056717}.
CC   -!- DISRUPTION PHENOTYPE: Deficient mice exhibit postnatal lethality,
CC       growth retardation, small lungs, abnormal cochlea morphology, abnormal
CC       kidney morphology, cardiovascular abnormalities and skeletal
CC       abnormalities. DCHS1 and FAT4 single mutants and DCHS1/FAT4 double
CC       mutants have similar phenotypes. {ECO:0000269|PubMed:18604206,
CC       ECO:0000269|PubMed:21303848, ECO:0000269|PubMed:24056717}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC27359.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAC28751.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ286572; ABB88946.1; -; mRNA.
DR   EMBL; AC122841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC161228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK031348; BAC27359.1; ALT_INIT; mRNA.
DR   EMBL; AK034552; BAC28751.1; ALT_INIT; mRNA.
DR   EMBL; BC079887; AAH79887.1; -; mRNA.
DR   CCDS; CCDS17325.1; -. [Q2PZL6-1]
DR   RefSeq; NP_899044.3; NM_183221.3. [Q2PZL6-1]
DR   RefSeq; XP_006535547.1; XM_006535484.3. [Q2PZL6-1]
DR   SMR; Q2PZL6; -.
DR   IntAct; Q2PZL6; 1.
DR   STRING; 10090.ENSMUSP00000061836; -.
DR   GlyConnect; 2656; 1 N-Linked glycan (1 site).
DR   GlyGen; Q2PZL6; 38 sites.
DR   iPTMnet; Q2PZL6; -.
DR   PhosphoSitePlus; Q2PZL6; -.
DR   MaxQB; Q2PZL6; -.
DR   PaxDb; Q2PZL6; -.
DR   PeptideAtlas; Q2PZL6; -.
DR   PRIDE; Q2PZL6; -.
DR   ProteomicsDB; 275590; -. [Q2PZL6-1]
DR   ProteomicsDB; 275591; -. [Q2PZL6-2]
DR   Antibodypedia; 62649; 109 antibodies.
DR   Ensembl; ENSMUST00000061260; ENSMUSP00000061836; ENSMUSG00000046743. [Q2PZL6-1]
DR   GeneID; 329628; -.
DR   KEGG; mmu:329628; -.
DR   UCSC; uc008pbe.1; mouse. [Q2PZL6-2]
DR   UCSC; uc008pbf.1; mouse. [Q2PZL6-1]
DR   CTD; 79633; -.
DR   MGI; MGI:3045256; Fat4.
DR   eggNOG; KOG1217; Eukaryota.
DR   eggNOG; KOG3594; Eukaryota.
DR   GeneTree; ENSGT00940000155719; -.
DR   HOGENOM; CLU_000042_1_0_1; -.
DR   InParanoid; Q2PZL6; -.
DR   OMA; LFTIGRQ; -.
DR   OrthoDB; 34489at2759; -.
DR   TreeFam; TF331335; -.
DR   BioGRID-ORCS; 329628; 0 hits in 52 CRISPR screens.
DR   ChiTaRS; Fat4; mouse.
DR   PRO; PR:Q2PZL6; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q2PZL6; protein.
DR   Bgee; ENSMUSG00000046743; Expressed in pineal body and 229 other tissues.
DR   Genevisible; Q2PZL6; MM.
DR   GO; GO:0045177; C:apical part of cell; IDA:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:InterPro.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0001658; P:branching involved in ureteric bud morphogenesis; IMP:MGI.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0021987; P:cerebral cortex development; IMP:UniProtKB.
DR   GO; GO:0072137; P:condensed mesenchymal cell proliferation; IMP:MGI.
DR   GO; GO:0048565; P:digestive tract development; IMP:MGI.
DR   GO; GO:0001736; P:establishment of planar polarity; IC:MGI.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IMP:MGI.
DR   GO; GO:0003007; P:heart morphogenesis; IMP:MGI.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IDA:UniProtKB.
DR   GO; GO:0035329; P:hippo signaling; IMP:UniProtKB.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0060122; P:inner ear receptor cell stereocilium organization; IMP:MGI.
DR   GO; GO:0001822; P:kidney development; IMP:MGI.
DR   GO; GO:0072006; P:nephron development; IMP:MGI.
DR   GO; GO:0022008; P:neurogenesis; IMP:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; IMP:MGI.
DR   GO; GO:0043931; P:ossification involved in bone maturation; IMP:MGI.
DR   GO; GO:0007009; P:plasma membrane organization; IMP:MGI.
DR   GO; GO:0072307; P:regulation of metanephric nephron tubule epithelial cell differentiation; IMP:MGI.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR001791; Laminin_G.
DR   Pfam; PF00028; Cadherin; 33.
DR   Pfam; PF00008; EGF; 2.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF12661; hEGF; 1.
DR   Pfam; PF02210; Laminin_G_2; 2.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 34.
DR   SMART; SM00181; EGF; 6.
DR   SMART; SM00179; EGF_CA; 5.
DR   SMART; SM00282; LamG; 2.
DR   SUPFAM; SSF49313; SSF49313; 34.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 2.
DR   PROSITE; PS00232; CADHERIN_1; 22.
DR   PROSITE; PS50268; CADHERIN_2; 34.
DR   PROSITE; PS00022; EGF_1; 7.
DR   PROSITE; PS01186; EGF_2; 3.
DR   PROSITE; PS50026; EGF_3; 6.
DR   PROSITE; PS01187; EGF_CA; 2.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..42
FT                   /evidence="ECO:0000255"
FT   CHAIN           43..4981
FT                   /note="Protocadherin Fat 4"
FT                   /id="PRO_0000324638"
FT   TOPO_DOM        43..4505
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        4506..4526
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        4527..4981
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          44..135
FT                   /note="Cadherin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          136..250
FT                   /note="Cadherin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          251..353
FT                   /note="Cadherin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          359..475
FT                   /note="Cadherin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          476..582
FT                   /note="Cadherin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          584..689
FT                   /note="Cadherin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          690..793
FT                   /note="Cadherin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          794..893
FT                   /note="Cadherin 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          894..996
FT                   /note="Cadherin 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          997..1100
FT                   /note="Cadherin 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1101..1210
FT                   /note="Cadherin 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1211..1315
FT                   /note="Cadherin 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1316..1420
FT                   /note="Cadherin 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1421..1529
FT                   /note="Cadherin 14"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1529..1629
FT                   /note="Cadherin 15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1630..1740
FT                   /note="Cadherin 16"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1741..1841
FT                   /note="Cadherin 17"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1842..1944
FT                   /note="Cadherin 18"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          1945..2051
FT                   /note="Cadherin 19"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2051..2154
FT                   /note="Cadherin 20"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2155..2259
FT                   /note="Cadherin 21"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2260..2364
FT                   /note="Cadherin 22"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2365..2468
FT                   /note="Cadherin 23"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2469..2569
FT                   /note="Cadherin 24"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2570..2671
FT                   /note="Cadherin 25"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2672..2775
FT                   /note="Cadherin 26"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2775..2874
FT                   /note="Cadherin 27"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2875..2985
FT                   /note="Cadherin 28"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          2986..3091
FT                   /note="Cadherin 29"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3092..3196
FT                   /note="Cadherin 30"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3197..3300
FT                   /note="Cadherin 31"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3301..3406
FT                   /note="Cadherin 32"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3407..3512
FT                   /note="Cadherin 33"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3511..3622
FT                   /note="Cadherin 34"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          3804..3862
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          3864..3900
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          3902..3938
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          3940..3976
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          3977..4161
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          4164..4200
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          4219..4399
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          4427..4464
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          4708..4797
FT                   /note="Necessary and sufficient for interaction with MPDZ"
FT                   /evidence="ECO:0000269|PubMed:19506035"
FT   MOD_RES         4878
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:15345747"
FT   CARBOHYD        84
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        237
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        393
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        416
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        435
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        483
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        551
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        615
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        676
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        721
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        825
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        880
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        948
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1085
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1225
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1296
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1389
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1514
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1828
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1899
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1967
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2119
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2387
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2432
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2923
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        2939
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3038
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3142
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3219
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3479
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3708
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        3760
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4019
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4269
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        4314
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        3808..3819
FT                   /evidence="ECO:0000250"
FT   DISULFID        3813..3850
FT                   /evidence="ECO:0000250"
FT   DISULFID        3852..3861
FT                   /evidence="ECO:0000250"
FT   DISULFID        3868..3879
FT                   /evidence="ECO:0000250"
FT   DISULFID        3873..3888
FT                   /evidence="ECO:0000250"
FT   DISULFID        3890..3899
FT                   /evidence="ECO:0000250"
FT   DISULFID        3906..3917
FT                   /evidence="ECO:0000250"
FT   DISULFID        3911..3926
FT                   /evidence="ECO:0000250"
FT   DISULFID        3928..3937
FT                   /evidence="ECO:0000250"
FT   DISULFID        3944..3955
FT                   /evidence="ECO:0000250"
FT   DISULFID        3949..3964
FT                   /evidence="ECO:0000250"
FT   DISULFID        3966..3975
FT                   /evidence="ECO:0000250"
FT   DISULFID        4135..4161
FT                   /evidence="ECO:0000250"
FT   DISULFID        4168..4179
FT                   /evidence="ECO:0000250"
FT   DISULFID        4173..4188
FT                   /evidence="ECO:0000250"
FT   DISULFID        4190..4199
FT                   /evidence="ECO:0000250"
FT   DISULFID        4366..4399
FT                   /evidence="ECO:0000250"
FT   DISULFID        4431..4442
FT                   /evidence="ECO:0000250"
FT   DISULFID        4436..4452
FT                   /evidence="ECO:0000250"
FT   DISULFID        4454..4463
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1975..1978
FT                   /note="VNSQ -> MSFL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_032339"
FT   VAR_SEQ         1979..4981
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_032340"
FT   CONFLICT        1481
FT                   /note="S -> N (in Ref. 1; ABB88946)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   4981 AA;  540316 MW;  D0436BAC3162CFD2 CRC64;
     MNLAANRAPG RRRLPLPSPS LCQLLRVWGL LSLLPGSARV QAAEQRQVFQ VMEEQPPGTL
     VGTIPTRPGF TYRLSESHAL FAINSSTGAL YTTATIDRES LPSDVVNLVV LSSSPTYPTE
     VRVLVRDLND NAPVFPDPSI VVTFKEDSGS GRQVILDTAT DSDIGSNGVD HHSYRIVSGN
     EAGRFRLDIT LNPSGEGAFL HLVSKGGLDR EVTPQYQLLV EVEDKGEPKR RGYLQVNVTV
     QDINDNPPVF GSSHYQAGVP EDAVVGSSVL QVAAADADEG TNADIRYRLQ DEGTPFQMDP
     ETGLITVREP LDFEARRQYS LTVQATDRGV PSLTGRAEAF IQLLDVNDND PVVKFRYFPA
     TSRYASVDEN AQVGTVVALL TVTDADSPAA NGNISVQILG GNEQRHFEVQ RSKVPNLSLI
     KVASALDRER IPSYNLTVSV SDNSGAPPTA EVQARSSVAS LVIFVNDIND HPPVFEQQVY
     RVNLSEEVPP GSYVSGVSAT DGDSGLNANL RYSIVSGNGL GWFHISEHSG LVTTSAAGGL
     DRELASQIVL NISARDQGVH PKVSYAQLVV TVLDVNDEKP VFSQPEGYEV SVVENAPTGT
     ELLVLGATDR DLGDNGTVRF SLQEAENDQR LFRLDPVSGR LSTASSLDRE EQAFYCLSIL
     ATDLGSPPQS STAQVNVSLL DINDNSPVFY PVQYFAHIQE NEPGGSYVTT VSATDPDMGP
     NGTVKYSISA GDRSRFQIHA KSGVISTKMA LDREEKTAYQ LQVVATDGGN LQSPNQAIVT
     VTVLDTQDNP PVFSQAAYSF VVFENVALGY HVGSVSATTM DLNANISYLI TTGDQRGMFA
     MNPVTGQLTT ASVIDREEQS FYQLKIVASG GAVTGDTVVN ITVKDLNDNA PHFLQAVESI
     NAVENWQAGH SIFQAKAVDP DEGVNGRVLY SLKQNPKNLF TINEQNGNIS LLGALDVHAG
     SYQVEIVASD MGVPQLSSSI LLTVYVHDVN DNPPVFDQIS YEVTLSESEP VNSRFFKVQA
     SDKDSGANGE IAYTITDGNN GDAFGIFPDG QLYIKSELDR ELQDRYVLLV VASDRAVEPL
     SATVNVTVLL EDVNDNRPLF NSTNYTFYFE EEQRAGSFVG KVSAVDKDFG PNGEVRYAFE
     VTQPNFELHA VTGEITSTHK FDRESLMRRR GTAVFSFTVT AMDRGLPQPL KDQATVHVYM
     KDINDNAPKF LKDFYQATVS ETATNLTQVL RVSASDVDEG SNGLIHYSIL KGNEERQFAI
     DSFSGQVTLV GKLDYEATSA YSLLIQAVDS GAIPLNSTCT LSIDILDEND NTPSFPKSTL
     FVDVLENMRI GELVSSVTAT DSDSGVNADL HYTITGSNNH GTFSISPNTG SIFLAKKLDF
     ETQSLYKLNI TAKDQGRPPR SSTMSVVIQV RDFNDNPPSF PPGDIFKSIV ENIPLGTSVI
     SVTAHDPDAD INGQLSYAII QQMPRGNHFS IDEVKGTIYT SAEIDREFAN LFELTVKAND
     QAVPIETRRY ALKNVTILVT DLNDNVPMFI SQNALAADPS AMIGSVLTTI MAADPDEGAN
     GEVEYEILNG DTDTFTVDRY SGDLRVASAL VPSQLIYNLI VSATDLGPER RKSTTELTVI
     LQGLDGPVFT QTKYITILKE GEPIGTNVIS IEAASPRGSE APVEYYIVSV RCEEKTVGRL
     FTIGRQTGVI QTAAILDREQ GACLYLVDVY AIEKSSAFPR TQRAEVEITL QDINDNPPVF
     PTDTLDLTVE ENIGDGSKIM QLTAMDADEG ANALVTYALI SGADDSFRID PESGDLIATK
     RLDREHRSKY SLLVRADDGL QSSDMRINIT ISDVNDHTPR FSRPVYSFDI PEDTTPGSLV
     AAILATDDDS GVNGEISYVV EEDDGDGVFF LNLVTGVFNL TRALDYETQQ YYILTVRAED
     GGGQSTTIRA YFNILDVNDN PPVFSMSSYS TSLMENLPLG STVLVFNVTD ADDGVNSQLS
     YSIASGDSLG QFAVDKHGVL KTLKALDRES QSFYNLVIQV HDLPQPPTSR FTSTAQVSII
     LLDVNDNPPM FLSPKLTYIP ENTPIDTVVF KAQATDPDSG PNSYIEYTLL NPSGNKFSIG
     TIDGEVHLTG ELDREEVSNY SLTVVATDKG QPPLSSSTEV VVMVLDINDN NPVFAQAMYR
     VQIKENILTG TDIIQVSAAD NDEGTNGQVR YGIVGGNTHQ EFRIDSVTGA ITVAKSLDRE
     TTPAYTLTVQ ATDRGSSPRT DSCTVAITLL DMNDFVPVFE LSPYSVNVPE NLGTLPRAIL
     QVVARDDDQG PNSQLSYVLL GGNEDNAFVL TASGELRVTQ SLDREARDHF VLVVTAADAG
     SPALTGTGTI NIIVDDINDN VPTFANNMYL TSIAEDARTG TDVLLVNASD ADAAANAVIS
     YSIIGGNSQF TINPSTGQII TSALLDRETK DNYTLVVVAS DAGSPESLSS STSVLVTITD
     VNDNPPRFQH HPYVTHIPSP TPPGSFVFAV TVTDADIGSN SELHYSLSGR NSEKFHIDPL
     RGAIMAAGPL SGASEVTFSV HVKDGGSFPK TDSTTVTVRF ANKADFPKVR AKEQTFMFPE
     NQPVGTLVTT ITGSSLRGET LSYYIASGNL GDTFQIDPLT GQVSISQPLD FEKIQKYVVW
     IEARDGGFPP FSSYEKLDIT VLDINDNAPT FEEDPFVSEI LENLSPRKIL TVSATDKDSG
     PNGQLDYEIV NGNQESSFTI NHATGEIRSI RPLDREKISH YELTVKSSDK GSPSQSTSVK
     VIISILDEND NAPRFSQIFS AYVSENSPLG YTVTRVTTSD EDIGINAISR YSIVDTSLPF
     TINPNTGDIV ISRPLNREDT DRYRIRVSAH DSGWTVSTDV TIFVTDINDN TPRFSRPSYY
     LDCPELPELG SRVTQVSATD PDEGSNGQVF YFIKSQSEYF RINATTGEIF NKQVLKYQNV
     SGFSNVNINR HSFIVTASDR GNPSLLSETT VTINTVDSND NPPQFLQNKY FTPVTKNVKV
     GTKLIKVTAV DDKDFGLNSE VEYFVSDGNH LGKFKLDNDT GWISIASSLV SDLNQNFLIR
     VTAKDKGNPP LSSQAVVHIT VTEENYHTPE FSQNHISATI PESHSIGSVV RTVSARDRDT
     AMNGLISYNI ISGNEEGIFA INSSTGVVTL AKALDYEMSS KHEMTISATD GGWVARTGYC
     SLTVSVIDVN DNSPVFVPDE FFPTVMENAP SGTTVIHLNA TDADSGANAV IAYTVQSSDS
     DLFVIDPNMG VITTQGFLDF ETKQSYHLTV KAFNVPDEEK CSFATVDIQL KGTNEYVPRF
     VSKLYYFEVS EAASRGTAVG EVFASDRDMG ADGEVHYLIF GNSRKKGFQI NKMTGQIYVS
     GLLDREKEER VSLKVLAKNF GNIRGADIDE VTVNITVLDA NDPPVFSLST YRVQISEGVP
     IGTHVTFVSA FDSDSIPSWS RFSYFIGSGN ENGAFSINPQ TGQITVTSGL DRESLPVYNL
     TVLAVDSGTP SATGSASLVV TLEDINDNGP VLTVSEGEVL ENKRPGTLVM TLQSTDPDLP
     PNQGPFNYYL LSTGPATNYF SLSTAGVLST TREIDREQIA DFYLSVVTRD SGAPQMSSTG
     TVHITVLDQN DNPSQSRTVE IFVNYYGNLF PGGTLGSVKP QDPDVLDSFH CSLTSGVTSL
     FSIPAGSCDL SSQPRSTDGT FDLTVVSSDG VHSTVTNNIR VFFAGFSNAT IDNSILLRVG
     VPTVKDFLTN HYLHFLRIAS SQLTGLGTAV QLYAAYEENN RTFLLAAVKR NNNQYVNPSG
     VATFFESIKE ILLRQSGVKV ESVDHDPCIH GPCQNGGSCL RRLAVGSALK IQESLPVIIV
     ANEPLQPSQC KCVPGYAGSW CEVDIDECLP APCHNGGTCH NLVGGFSCSC PEGFTGRACE
     RDINECLPSP CKHGAVCQNF PGGFNCVCKT GYTGKMCESS VNYCECNPCF NGGSCQSGVE
     SYYCHCPFGV FGKHCELNSY GFEELSYMEF PSLDPNNNYI YVKFATIKSH ALLLYNYDNQ
     TGERAEFLAL EIAEERLRFS YNLGSGTYKL TTMKKVSDGQ FHTVIARRAG MAASLTVDSC
     SENQEPGYCT VSNVAVSDDW TLDVQPNRVT VGGIRSLEPI LQRRGHVESH DFVGCVMEFA
     VNGRPLEPSQ ALAAQGILDQ CPRLEGTCAR NPCQHGGTCV DFWSWQQCQC MEGLTGKYCE
     KSVTPDTALS LEGKGRLDYH MSQSEKREYL LTQSIRDTTL EPFGVNSLEV KFRTRSENGI
     LIHIQESSNY TTVKIKNGKV HFTSDAGVAG KVERIIPEAY IADGHWHTFR ISKNGSITVL
     SVDRIHNRDI VHPTQDFGGI EVLSMSLGGI PPNQAHRDTQ TGFNGCIASV LYGGESLPFS
     GKHSLASISK TDPSVKIGCR GPNICASNPC WGDLLCINQW YAYKCVPPGD CASHPCQNGG
     SCEPGLLSGY TCSCPESHTG RTCETVVACL GVLCPQGKVC KAGSPGGHVC VQSQGPDEIS
     LPLWAVPAIV GSCATALALL VLSLILCNQC RGKMPKNPKE EKKPKEKKKK GSENVAFDDP
     DNIPPYGDDL AVRKQPEGNP KPDIIERENP YLIFDETDIP HNSETIPSAP LASPEQEIEH
     YDIDNASSIA PSDADIIQHY KQFRSHTPKF SIQRHSPLGF ARQSPMPLGA SSLTYQPSSY
     GQGLRTSSLS HSACPTPNPL SRHSPAPFSK PSAFYRNSPA RELHLPLRDG GTLEMHGDPC
     QPGMFNYATR LGRRSKSPQA MASHGSRPGS RLKQPIAQIP LESSPPVGLS IEEVERLNTP
     RPRNPSICSA DHGRSSSEED CRRPLSRTRN PADGIPAPES SSDSDSHDSF TCSEMEYDRE
     KPVVYTSRMP KLSQVNESDA DDEDNYGARL KPRRYHGRRA EGGPVGTPAA ASGAADSTLK
     LGQQAGNFNW DNLLNWGPGF GHYVDVFKDL ASLPEKAAGN EEGKSGAAKP AAKDGEAEQY
     V
//
